Komori
Nippon Sheet Glass (5202) · RiskContinuing impact of China's lockdowns

Impact of COVID-19 on Demand, Production and Logistics

First written in FY2020. 5 of 10 entries say "Mitigated", first in FY2021-Q3. Latest entry: FY2023.

10entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseMaterialisedFY2021-Q1 – FY2021-Q2MitigatedFY2021-Q3 – FY2022-Q3OtherFY2023-Q3 – FY20232020: 320202021: 420212022: 120222023: 22023
Same theme, other companies
Impact of COVID-19 on business operations, demand, human mobility, and supply chainsA theme 71 companies write about · 71 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2025: 5 of 16 companies on the "Worse" side.

1 other company's latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 71 companies compared. The sentences above are computed from all 71.
Full recordFilings, disclosures and news, newest first
  1. FY2023Continuing impact of China's lockdownsAnnual report

    「High-performance glass was affected in the second half by COVID-19-related lockdowns in China and a slowdown in the IT market, but was generally stable.」

    While the overall impact of COVID-19 eased, the high-performance glass business continued to be affected in the second half by lockdowns in China and the slowdown in the IT market.
  2. FY2023-Q3Continuing impact of China's lockdownsAnnual report

    「The current third quarter continued to be affected by the spread of COVID-19 in China and the resulting lockdowns.」

    While the overall impact of COVID-19 on demand and production has eased, the high-performance glass business continued to be affected by the spread of COVID-19 and lockdowns in China during the third quarter.
  3. FY2022-Q3MitigatedAnnual report

    「Cumulative revenue improved substantially compared with the same period of the previous year, which was heavily affected, particularly in the first quarter, by lockdown restrictions following the spread of COVID-19.」

    Cumulative revenue improved substantially compared with the same period of the previous year, when the impact of COVID-19 lockdowns was significant, indicating that the financial impact had eased.
  4. FY2022-Q2MitigatedAnnual report

    「Because COVID-19-related costs were not material compared with the cumulative second quarter of the previous fiscal year, they were not recognised as individually disclosed items (expenses) for the six months ended the current second quarter.」

    Costs from COVID-19-related facility shutdowns and other measures were less material than in the same period of the previous year and were not recognised as individually disclosed items for the six months ended the current second quarter. Separately, ¥404 million in income from government support was recognised.
  5. FY2022-Q1MitigatedAnnual report

    「Net individually disclosed items amounted to ¥200 million, a substantial decrease from the ¥11.5 billion recorded in the same period of the previous year, which included individually disclosed items related to COVID-19.」

    Individually disclosed items, including COVID-19-related costs, fell substantially from ¥11.5 billion in the same period of the previous year to ¥200 million in the current period, indicating that the financial impact of the pandemic had eased.
  6. FY2021MitigatedAnnual report

    「A cumulative ¥16.1 billion has been recognised as net individually disclosed items related to COVID-19. Most was incurred in the first quarter, with ¥2.1 billion recognised during the 3 months of the current fourth quarter.」

    COVID-19-related costs reached ¥16.1 billion cumulatively, most of which was incurred in the first quarter, while ¥2.1 billion was recognised during the 3 months of the fourth quarter.
  7. FY2021-Q3MitigatedAnnual report

    「Together with subsidies provided by governments in various countries in connection with COVID-19, these costs have totalled ¥14.0 billion as net individually disclosed items related to COVID-19. However, only ¥1.2 billion was recognised during the 3 months of the current third quarter, a substantial decrease in the amount recognised.」

    COVID-19-related costs for facility shutdowns, disinfection and temporary leave reached ¥14.0 billion cumulatively, but the amount recognised for the 3 months of the third quarter fell substantially to ¥1.2 billion. The impact remains, but has eased on a quarterly basis.
  8. FY2021-Q2MaterialisedAnnual report

    「COVID-19-related costs, including expenses associated with facility shutdowns caused by the spread of the infection, direct costs such as facility disinfection, and wages for employees on temporary leave, are separately disclosed in the income statement. Together with government subsidies received in connection with COVID-19, these amounted to ¥12.8 billion, recorded as net individually disclosed items related to COVID-19.」

    COVID-19-related costs, including facility shutdowns, disinfection expenses and wages for employees on temporary leave, were incurred, and ¥12.8 billion was recognised as individually disclosed items after deducting government subsidies.
  9. FY2021-Q1MaterialisedAnnual report

    「During the first quarter, the Group's business environment was significantly affected by a decline in demand resulting from the spread of COVID-19.」

    COVID-19-related declines in demand occurred in the architectural glass, automotive glass and high-performance glass businesses, and revenue fell 38% year on year.
  10. FY2020First statedAnnual report

    「The Group has also been affected by lockdowns in countries and cities, mainly in Europe and North and South America, as well as production cutbacks by customers, particularly automakers, and logistics disruptions. Temporary shutdowns and operating adjustments at Group sites and production lines have affected product manufacturing, product shipments and raw-material logistics.」

    The Company identified COVID-19 as a separate major risk for the first time and explained that lockdowns, customer production cutbacks, logistics disruptions, and impacts on production and shipments had already occurred.
Moved together

"Impairment Risk in Emerging-Market Businesses and Investments" moved the same way as this thread, in the same document, in 7 of its 10 moves.

765543★123456
  1. ★This thread
  2. 1Impairment Risk in Emerging-Market Businesses and Investments7×
  3. 2Decline in the Ratio of Equity Attributable to Owners of the Parent6×
  4. 3Risk of Economic Deterioration in Major and Emerging Markets5×
  5. 4First-quarter operating profit and profit attributable to owners of the parent turn profitable5×
  6. 5Debt Reduction through Profitability Improvement, Working Capital Management and Capital Expenditure Management4×
  7. 6Risk of raising funds required in the future3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Nippon Sheet Glass yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Impact of COVID-19 on Demand, Production and Logistics | Nippon Sheet Glass Company,Limited (5202) | Komori